Matches in SemOpenAlex for { <https://semopenalex.org/work/W2193369678> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2193369678 abstract "The aim of this study is to evaluate the clinical and endoscopic efficacy, and safety of infliximab therapy for UC following liver transplantation in patients with PSC. Methods: We evaluated all patients clear diagnosis of UC who underwent Orthotopic Liver Transplantation (OLT) at Ospedali Riuniti of Bergamo between January 2001 and September 2012 and who had received inflixamab therapy for refractory IBD following liver transplantation. Results: Four patients (all men; median age 39 years, range 22 54 years) with UC (3) and pouchitis (1) who underwent OLT were identified. Three patients (75%) experienced sustained improvement of IBD. Mucosal healing was observed in one of three patients (33%). Steroid treatment was interrupted during infiximab therapy in all patients. Adverse events included only one infection: molluscum contagiosum on face of one patient, treated with laser-therapy with resolution of symptoms. No malignancies were observed in all patients following infliximab therapy. No hepatic reject was documented while on infliximab therapy. One patient 25%) presented a recurrence of PSC two years before infliximab therapy (three years after OLT) and he underwent a second OLT after 5 years after the first. Conclusions: Infliximab therapy appears to be effective in patients with refractory ulcerative colitis after liver transplantation. Although no complications of hepatic graft function or reject were observed, additional largest studies are need to evaluate the safety’s profile of biological therapy combined to anti-reject treatment in patients with refractory IBD following liver transplantation." @default.
- W2193369678 created "2016-06-24" @default.
- W2193369678 creator A5037885531 @default.
- W2193369678 creator A5062860652 @default.
- W2193369678 creator A5064428684 @default.
- W2193369678 creator A5079679417 @default.
- W2193369678 date "2013-05-01" @default.
- W2193369678 modified "2023-10-18" @default.
- W2193369678 title "Tu1167 Infliximab Is More Immunogenic and Reaches Lower Trough Levels in Ulcerative Colitis Patients Compared to Crohn's Disease Patients" @default.
- W2193369678 doi "https://doi.org/10.1016/s0016-5085(13)62883-8" @default.
- W2193369678 hasPublicationYear "2013" @default.
- W2193369678 type Work @default.
- W2193369678 sameAs 2193369678 @default.
- W2193369678 citedByCount "3" @default.
- W2193369678 countsByYear W21933696782015 @default.
- W2193369678 countsByYear W21933696782016 @default.
- W2193369678 countsByYear W21933696782017 @default.
- W2193369678 crossrefType "journal-article" @default.
- W2193369678 hasAuthorship W2193369678A5037885531 @default.
- W2193369678 hasAuthorship W2193369678A5062860652 @default.
- W2193369678 hasAuthorship W2193369678A5064428684 @default.
- W2193369678 hasAuthorship W2193369678A5079679417 @default.
- W2193369678 hasConcept C121332964 @default.
- W2193369678 hasConcept C126322002 @default.
- W2193369678 hasConcept C141071460 @default.
- W2193369678 hasConcept C142424586 @default.
- W2193369678 hasConcept C197934379 @default.
- W2193369678 hasConcept C2777138892 @default.
- W2193369678 hasConcept C2778260677 @default.
- W2193369678 hasConcept C2779134260 @default.
- W2193369678 hasConcept C2779609443 @default.
- W2193369678 hasConcept C2780132546 @default.
- W2193369678 hasConcept C2780479503 @default.
- W2193369678 hasConcept C2911091166 @default.
- W2193369678 hasConcept C71924100 @default.
- W2193369678 hasConcept C87355193 @default.
- W2193369678 hasConcept C90924648 @default.
- W2193369678 hasConceptScore W2193369678C121332964 @default.
- W2193369678 hasConceptScore W2193369678C126322002 @default.
- W2193369678 hasConceptScore W2193369678C141071460 @default.
- W2193369678 hasConceptScore W2193369678C142424586 @default.
- W2193369678 hasConceptScore W2193369678C197934379 @default.
- W2193369678 hasConceptScore W2193369678C2777138892 @default.
- W2193369678 hasConceptScore W2193369678C2778260677 @default.
- W2193369678 hasConceptScore W2193369678C2779134260 @default.
- W2193369678 hasConceptScore W2193369678C2779609443 @default.
- W2193369678 hasConceptScore W2193369678C2780132546 @default.
- W2193369678 hasConceptScore W2193369678C2780479503 @default.
- W2193369678 hasConceptScore W2193369678C2911091166 @default.
- W2193369678 hasConceptScore W2193369678C71924100 @default.
- W2193369678 hasConceptScore W2193369678C87355193 @default.
- W2193369678 hasConceptScore W2193369678C90924648 @default.
- W2193369678 hasLocation W21933696781 @default.
- W2193369678 hasOpenAccess W2193369678 @default.
- W2193369678 hasPrimaryLocation W21933696781 @default.
- W2193369678 hasRelatedWork W1970524014 @default.
- W2193369678 hasRelatedWork W1975645772 @default.
- W2193369678 hasRelatedWork W2023523628 @default.
- W2193369678 hasRelatedWork W2034646771 @default.
- W2193369678 hasRelatedWork W2080765540 @default.
- W2193369678 hasRelatedWork W2086501095 @default.
- W2193369678 hasRelatedWork W2091638250 @default.
- W2193369678 hasRelatedWork W2154997623 @default.
- W2193369678 hasRelatedWork W2160232557 @default.
- W2193369678 hasRelatedWork W2261504070 @default.
- W2193369678 hasRelatedWork W2329905916 @default.
- W2193369678 hasRelatedWork W2339581869 @default.
- W2193369678 hasRelatedWork W2519585566 @default.
- W2193369678 hasRelatedWork W2605523210 @default.
- W2193369678 hasRelatedWork W2609527651 @default.
- W2193369678 hasRelatedWork W2735054827 @default.
- W2193369678 hasRelatedWork W2744535196 @default.
- W2193369678 hasRelatedWork W2789490265 @default.
- W2193369678 hasRelatedWork W2793128472 @default.
- W2193369678 hasRelatedWork W3031959380 @default.
- W2193369678 isParatext "false" @default.
- W2193369678 isRetracted "false" @default.
- W2193369678 magId "2193369678" @default.
- W2193369678 workType "article" @default.